Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-25 Sale | 2023-05-25 9:01 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 63,186 | $1.2229 | $77,270 | 724,344 (Direct) | View |
| 2023-05-25 Sale | 2023-05-25 9:01 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 95,478 | $1.2229 | $116,760 | 774,037 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 6:20 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 63,567 | $1.068 | $67,890 | 530,487 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 6:19 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 63,567 | $1.068 | $67,890 | 446,483 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 91,868 | $0.8775 | $80,614 | 1,888,728 (Indirect Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 13,034 | $0.8775 | $11,437 | 287,530 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 14,123 | $0.8775 | $12,393 | 594,054 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 20,412 | $0.8775 | $17,912 | 269,515 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:00 am | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 7,210 | $0.8775 | $6,327 | 510,050 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:07 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 38,632 | $0.8132 | $31,416 | 1,980,596 (Indirect Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:06 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 7,539 | $0.8132 | $6,131 | 608,177 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:06 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 10,090 | $0.8132 | $8,205 | 289,927 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:05 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 7,539 | $0.8132 | $6,131 | 517,260 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:05 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 6,677 | $0.8132 | $5,430 | 300,564 (Direct) | View |
| 2022-08-31 Sale | 2022-09-01 4:15 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 1,147 | $0.3625 | $416 | 418,016 (Direct) | View |
| 2022-06-03 Sale | 2022-06-07 4:03 pm | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 4,567 | $0.362 | $1,653 | 43,430 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-07-31 Option Award | 2023-08-01 4:35 pm | N/A 2033-07-31 | Akebia Therapeutics Inc. | AKBA | Snow Ellen SVP, CFO and Treasurer | 930,000 | $0 | 930,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:08 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director | 75,000 | $0 | 88,700 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:08 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director | 75,000 | $0 | 141,029 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | FRIESON RON Director | 75,000 | $0 | 88,700 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 75,000 | $0 | 112,681 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 75,000 | $0 | 179,800 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director | 75,000 | $0 | 140,233 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 75,000 | $0 | 132,130 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 9:01 pm | N/A 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 200,000 | $0 | 724,344 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 9:01 pm | N/A 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 200,000 | $0 | 774,037 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:10 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 100,000 | $0 | 387,530 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:09 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 200,000 | $0 | 469,515 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:15 pm | N/A 2033-01-31 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 1,803,438 | $0 | 3,529,541 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:14 pm | N/A 2033-01-31 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 490,500 | $0 | 819,099 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:14 pm | N/A 2033-01-31 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 490,500 | $0 | 910,016 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 08:11 am | 2023-05-12 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 200,000 | $0 | 528,599 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:01 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director | 33,800 | $0 | 33,800 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:00 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 33,800 | $0 | 57,781 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:59 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director | 33,800 | $0 | 85,333 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:58 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director | 33,800 | $0 | 86,129 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:58 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 33,800 | $0 | 77,230 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:57 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | FRIESON RON Director | 33,800 | $0 | 33,800 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:56 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 33,800 | $0 | 124,900 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 4:08 pm | 2023-05-12 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 200,000 | $0 | 617,663 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 4:04 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer | 150,000 | $0 | 219,954 (Direct) | View |